Arundhati Parmar / MedCity News:
Anagenex, which combines AI and large-scale proprietary datasets for drug discovery, has raised a $30M Series A led by Catalio Capital Management — The CEO of Anagenex believes that the company’s AI engine trained on billions of data points and iterative testing will blow other AI drug discovery startups out of the water.
